Detalles de la búsqueda
1.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Hematol Oncol
; 38(3): 244-256, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067259
2.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610279
3.
Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.
Eur Stroke J
; : 23969873241242239, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38567789
4.
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists - the RIC-ICH study.
Front Neurol
; 14: 1212495, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37554390
5.
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study.
Int J Stroke
; 18(10): 1169-1177, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306492
6.
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study.
Eur Stroke J
; 6(4): 438-444, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342819
7.
Calculating the number of undetected active SARS-CoV-2 infections from results of population-wide antigen tests.
J Med Life
; 14(6): 797-801, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35126750
8.
Excess mortality due to Covid-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden and Spain.
PLoS One
; 16(8): e0255540, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34343210
9.
Excess mortality due to COVID-19 in Germany.
J Infect
; 81(5): 797-801, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32956730
10.
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination.
Data Brief
; 28: 104976, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31890813
11.
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial.
Eur J Cancer
; 124: 25-36, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31710995
12.
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 36(20): 2024-2034, 2018 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750632
13.
Corrigendum to 'Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial' [Eur J Canc 124 (January 2020) 25-36].
Eur J Cancer
; 136: 207-208, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32651046
Resultados
1 -
13
de 13
1
Próxima >
>>